OTC Artificial Tears Market Size, Share & Trends Analysis Report By Product (Solutions, Ointments, Emulsions, Gels, Spray Solutions, Suspensions), By Container Type (Single-Dose Plastic, Multi-Dose Plastic, Others), By Type (Cellulose-Based, Glycerin-Based, Oil-Based Emulsion, Polyethylene Glycol), By Delivery Method (Eye Drops, Ointments), By Application (Dry Eye Treatment, Contact Lens Moisture), By Formulation (Preservative-Based, Non-Preservative-Based), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Otc Artificial Tears Market Size

The global otc artificial tears market size was valued at USD 5569.95 million in 2025 and is projected to grow from USD 5854.02 million in 2026 to USD 8715.17 million by 2034, registering a CAGR of 5.1% during the forecast period from 2026 to 2034. North America dominated the otc artificial tears market with a market share of 38.6% in 2025.

Artificial tears are applied to protect and moisturize mucous membranes and alleviate dryness and irritation of the eyes. Artificial Tears is a specially formulated eye moisturizing solution. These eye drops can treat dry eyes caused by aging, specific medications, a medical condition, eye surgery, or environmental factors such as windy or smoky conditions. Artificial Tears alleviate the discomfort, irritation, and burning caused by dry eyes. Over-the-counter (OTC) artificial tears are those available without a prescription and sold directly to consumers. In addition to lubricating the eyes, certain artificial tears promote healing of the eyes, while others work to reduce tear evaporation. Artificial tears may also comprise thickening agents that keep the solution on the eye's surface for extended periods.

The global market for over-the-counter (OTC) artificial tears is primarily driven by an increase in the geriatric population, an alarming rise in the prevalence of dry eye syndrome (DES), and an increase in the number of eye surgeries, which leads to the rise for artificial tear drops for post-surgery management. In addition, changes in lifestyle habits, such as prolonged exposure to digital displays and an increase in the number of smartphone addicts, lead to dry eye syndrome, which increases the demand for artificial tears and drives market growth. Moreover, as the number of eye surgeries rises, so does the need for artificial tear drops for post-operative care.

Product Type Insights

The solution type will have the largest share in the OTC artificial tears market, growing at a CAGR of 5.13% during the forecast period. The solution is a sterile liquid formulation that contains one or more chemical entities and active pharmaceutical ingredients dissolved in an appropriate solvent. Emollients and demulcents are the two main ingredients in artificial tear solutions. Due to an increase in demand for eye drops, the production of artificial tears for treating eye diseases, and advancements in ophthalmology research, the solution segment will dominate the market over the forecast period.

The ointment type will have the second-largest share. There are available semisolid and greasy eye ointments. These are directly injected into the conjunctiva sac and placed between the lower eyelid and the eyeball. The increase in demand for eye ointment, the incidence of dry eye syndrome and allergic conjunctivitis, and the number of key players manufacturing combinational semisolid ophthalmic drugs all contribute to the market's expansion.

Request Customizationto receive a tailored report.

Depending on Container Type Insights

Plastic Multi-Dose Container is anticipated to have the largest share during the forecast period advancing a CAGR of 5.35%. Multiple-dose containers of plastic dropper bottles contain 10 milliliters of artificial tears solution for administration multiple times. The plastic multi-dose container contains a preservative solution to prevent the spread of pathogens. The rising prevalence of glaucoma and cataract, increase in the number of eye surgeries, government initiatives for the advancement of the healthcare industry, and advances in ophthalmology R&D are the key factors driving the OTC artificial tears market growth.

Plastic Single-Dose Container will have the second-largest share. The eye lubricant required for a single administration of the drug is contained in a small, transparent plastic vial containing an adequate quantity of eye lubricant for a single administration. Due to an increase in the aging population, the prevalence of dry eye syndrome, and the awareness of eye health management, it is anticipated that the plastic single-dose container segment will experience substantial market growth over the forecast period.

Depending on the Formulation Insights

Preservative-based will have the largest market share growing at the highest CAGR of 5.21% during the forecast period. A preservative is a chemical added to various products, such as food, beverages, and pharmaceutical drugs, to prevent microbial growth-induced decomposition. The artificial tears product includes preservatives to keep the solution sterile for a more extended period and prevent eye infections. Due to an increase in demand for eye drops, a rise in the production of artificial tears for the treatment of dry eye diseases, and advances in research and development for novel preservative-free artificial tears, this segment will dominate throughout the forecast period.

The non-preservative-based solution does not comprise a preservative agent. The preservative-free solution for artificial tears was available in single-use vials. Due to an increase in eye surgeries and technological advancement, the non-preservative-based market is anticipated to experience significant growth over the coming years.

Application Insights

Dry eye syndrome will hold the largest market share during the forecast period, advancing a CAGR of 4.63%. Dry eye syndrome is a chronic condition characterized by inadequate lubrication of the eyes by tears. Redness, itching, and burning sensation are some of the most common symptoms of dry eye. Changes in lifestyle habits, such as unsuitable diet and prolonged use of phones and laptops, are among the most influential factors in the onset of dry eye in the general population. Demand for over-the-counter (OTC) artificial tears used to treat dry eye conditions is fueled by an increase in the prevalence of eye disease among the geriatric population and a surge in digitalization, thereby contributing to the expansion of the global OTC artificial tears market.

Allergies will have the second-largest share. Eye allergies, also known as allergic conjunctivitis, are caused by the contact of an irritant (known as allergens) with the eyes. Eye allergies are one of the most prevalent diseases affecting people of all ages. Demand for the manufacturing and development of adequate anti-allergic over-the-counter artificial tears drives the market expansion.

Distribution Channels Insights

Drug Stores & Retail Pharmacies are expected to hold the largest market share during the forecast period growing at a CAGR of 4.87%. The pharmacies sell the medications with or without prescriptions. The purpose of pharmacies in drug stores is to provide clinical services and accurate drug information to customers. Demand for over-the-counter artificial tear medications and government initiatives to advance the healthcare industry are the primary factors driving market expansion. The increase in digital technology adoption and screen time increases the demand for over-the-counter artificial tears.

Hospital pharmacies will have the second-largest share. Due to an increase in dry eye syndrome and allergic conjunctivitis, the hospital pharmacies segment is anticipated to experience substantial market growth during the forecast period. The most demanding production in hospital pharmacies is the sterile production of artificial tears drugs, conducted under the guidance of good manufacturing practices (GMPs).

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is most likely to hold the largest market share during the forecast period growing at a CAGR of 4.57%. North America will continue to dominate the market in terms of revenue during the forecast period, owing to the increasing prevalence of geriatrics, the expansion of healthcare infrastructure, the deployment of sophisticated products, and the presence of market leaders. The increasing incidence of dry eye syndrome and advances in ophthalmology R&D are anticipated to drive market growth.

In addition, the increase in the number of eye surgeries is anticipated to contribute to the region's dominance during the study period. For example, according to figures released by the Centers for Disease Control and Prevention (CDC), more than 4.2 million Americans aged 40 and older have legal blindness or low vision. Cataracts and glaucoma are the leading causes of blindness in the U.S.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Second-Largest Market

Europe will have the second-largest market share of USD 2,008 million, growing at a CAGR of 5.25% by 2030. The spike in the proportion of cataract surgeries, the existence of key market players, technological advances in the healthcare sector, and the adoption of contact lenses are the primary factors driving the market growth. Europe's growing technical advancement in ophthalmology is viewed as the market's primary driving force. Due to the rapid adoption of artificial tears in Europe, the market for artificial tears sold over the counter is increasing. Demand for over-the-counter (OTC) artificial tears to alleviate itching, irritation, redness, and burning sensations increases as cataract surgery becomes more prevalent in Europe.

Asia-Pacific: Growing Highest Cagr during Forecast Period

Due to an increase in the elderly population, the number of cataract and glaucoma surgeries, and environmental pollution, the Asia-Pacific market is anticipated to experience significant growth over the forecast period. China and India have many patients suffering from dry eye, making them highly attractive investment markets. Moreover, the increase in the number of patients diagnosed with dry eye syndrome and the rise in awareness programs for the prevention and management of ocular disease is anticipated to provide growth offers for the manufacturer of novel artificial tear products and boost the growth of the global market for over-the-counter artificial tears.

Increase in the geriatric population, increase in cataract and glaucoma surgeries, and advances in R&D drive market growth. Environmental pollution is one of the leading causes of ocular disease, which in turn causes irritation and dry eye syndrome. In addition, China's pollution index of 81.12 indicates an increase in environmental pollution. Those who reside in areas with a high risk of air pollution are more likely to suffer from dry eye disease.

List of Key and Emerging Players in OTC Artificial Tears Market